Pure Global

Point of Care Test of LTA Level in Tear Fluid, Measured With a POCT Test, in DE Patients Following IPL Treatment - Trial NCT06269237

Access comprehensive clinical trial information for NCT06269237 through Pure Global AI's free database. This phase not specified trial is sponsored by He Eye Hospital and is currently Not yet recruiting. The study focuses on Dry Eye. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06269237
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06269237
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Point of Care Test of LTA Level in Tear Fluid, Measured With a POCT Test, in DE Patients Following IPL Treatment

Study Focus

Dry Eye

M22

Interventional

device

Sponsor & Location

He Eye Hospital

Timeline & Enrollment

N/A

Feb 22, 2024

Jul 01, 2024

30 participants

Primary Outcome

LTA,Non-invasive tear break-up time (NITBUT)

Summary

To quantify and compare tear levels of Intense pulsed light (IPL) and traditional dry eye
 clinical tests in dry eye patients before and after Intense pulsed light (IPL) treatment.

ICD-10 Classifications

Ocular pain
Avulsion of eye
Other corneal deformities
Corneal ulcer
Dry mouth, unspecified

Data Source

ClinicalTrials.gov

NCT06269237

Device Trial